Small Molecule Multi-Targeted Kinase Inhibitor RGB-286638 Triggers P53-Dependent and -Independent Anti-Multiple Myeloma Activity through Inhibition of Transcriptional CDKs

Small molecule multi-targeted CDK inhibitors (CDKIs) are of particular interest due to their potent antitumor activity independent of p53 gene alterations. P53 deletion is associated with a very poor prognosis in multiple myeloma (MM). In this regard, we tested the anti-MM activity of RGB-286638, an...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Cirstea, Diana, Hideshima, Teru, Santo, Loredana, Eda, Homare, Mishima, Yuko, Nemani, Neeharika, Hu, Yiguo, Mimura, Naoya, Cottini, Francesca, Gorgun, Gullu, Ohguchi, Hiroto, Suzuki, Rikio, Loferer, Hannes, Munshi, Nikhil C., Anderson, Kenneth C., Raje, Noopur
פורמט: Artigo
שפה:Inglês
יצא לאור: 2013
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3928098/
https://ncbi.nlm.nih.gov/pubmed/23807770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2013.194
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים